(2S)-3-(3-methoxy-4-methylphenyl)-N-methyl-2-[[2-[1-(5-phenylmethoxypyridin-3-yl)naphthalen-2-yl]sulfanylacetyl]amino]propanamide
(2S)-3-(3-methoxy-4-methylphenyl)-N-methyl-2-[[2-[1-(5-phenylmethoxypyridin-3-yl)naphthalen-2-yl]sulfanylacetyl]amino]propanamide
| SMILES |
CC1=C(C=C(C=C1)C[C@@H](C(=O)NC)NC(=O)CSC2=C(C3=CC=CC=C3C=C2)C4=CC(=CN=C4)OCC5=CC=CC=C5)OC |
| InChIKey |
IBQRWMDLUKSOJL-HKBQPEDESA-N |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Molecular weight (Da) |
|
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
(2S)-3-(3-methoxy-4-methylphenyl)-N-methyl-2-[[2-[1-(5-phenylmethoxypyridin-3-yl)naphthalen-2-yl]sulfanylacetyl]amino]propanamide
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.